We are live on
!
Find out more
BRA
Bender Robert & Associates Portfolio holdings
AUM
$417M
1-Year Est. Return
25.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.47%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$463M
AUM Growth
+$14.3M
(+3.2%)
Cap. Flow
-$6.93M
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
73.85%
Holding
47
New
1
Increased
2
Reduced
31
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$638K |
| 2 |
Palo Alto Networks
PANW
|
+$123K |
| 3 |
Chubb
CB
|
+$59.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.04M |
| 2 |
Apple
AAPL
|
+$1.72M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$444K |
| 4 |
Chipotle Mexican Grill
CMG
|
+$411K |
| 5 |
Meta Platforms (Facebook)
META
|
+$384K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 47.29% |
| 2 | Consumer Discretionary | 21.54% |
| 3 | Healthcare | 13.93% |
| 4 | Communication Services | 13.56% |
| 5 | Financials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$422B
| $1.3M | 0.28% |
1,404
-41
| -3% | -$39.3K |
|
27
JPMorgan Chase
JPM
$947B
| $809K | 0.17% |
2,565
-5
| -0.2% | -$1.49K |
|
28
UroGen Pharma
URGN
$2.02B
| $692K | 0.15% |
34,701
| – | – |
|
29
AbbVie
ABBV
$454B
| $690K | 0.15% |
2,982
-350
| -11% | -$71.3K |
|
30
Johnson & Johnson
JNJ
$641B
| $655K | 0.14% |
3,532
-20
| -0.6% | -$3.43K |
|
|
31
GE Vernova
GEV
$265B
| $647K | 0.14% |
+1,053
| New | +$638K |
|
32
Oracle
ORCL
$345B
| $566K | 0.12% |
2,014
| – | – |
|
33
Abbott
ABT
$182B
| $544K | 0.12% |
4,065
-50
| -1% | -$6.56K |
|
34
Caterpillar
CAT
$402B
| $489K | 0.11% |
1,024
| – | – |
|
35
Deere & Co
DE
$169B
| $449K | 0.1% |
982
| – | – |
|
36
Merck
MRK
$323B
| $404K | 0.09% |
4,812
-100
| -2% | -$8.24K |
|
37
Visa
V
$689B
| $343K | 0.07% |
1,004
-47
| -4% | -$16.3K |
|
38
Nucor
NUE
$56.4B
| $328K | 0.07% |
2,425
| – | – |
|
39
Gilead Sciences
GILD
$162B
| $313K | 0.07% |
2,819
-50
| -2% | -$5.68K |
|
40
Broadcom
AVGO
$1.82T
| $256K | 0.06% |
775
| – | – |
|
41
Invesco S&P 500 Equal Weight ETF
RSP
$97.1B
| $242K | 0.05% |
1,274
| – | – |
|
42
American Electric Power
AEP
$72.7B
| $231K | 0.05% |
2,050
| – | – |
|
43
Duke Energy
DUK
$100B
| $229K | 0.05% |
1,848
| – | – |
|
44
Pulse Biosciences
PLSE
$2.27B
| $205K | 0.04% |
11,590
| – | – |
|
45
BioCryst Pharmaceuticals
BCRX
$2.43B
| $180K | 0.04% |
23,710
| – | – |
|
46
Evolus
EOLS
$407M
| $154K | 0.03% |
25,070
| – | – |
|
47
Paychex
PAYX
$41.1B
| – | – |
-1,455
| Closed | -$212K |
|
Similar funds
AWCI
ACM
PA
CEI
MCM
SSC
SCP
VM
Bender Robert & Associates's Q3 2025 Portfolio in Review
As of Q3 2025, Bender Robert & Associates held 47 positions worth $463M, up 3.2% from $448M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.3%. Bender Robert & Associates opened 1 new position and exited 1, leaving the 47-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bender Robert & Associates's largest Q3 2025 buy was GE Vernova: 1,053 shares worth $647K.
- Bender Robert & Associates added most to Palo Alto Networks in Q3 2025, an estimated $123K increase.
- Bender Robert & Associates's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.04M.
- Bender Robert & Associates fully exited Paychex in Q3 2025, selling an estimated $212K.
- Bender Robert & Associates's ten largest holdings make up 74% of its $463M portfolio in Q3 2025.
- Bender Robert & Associates opened 1 new position and closed 1 in Q3 2025.
- Bender Robert & Associates's portfolio value rose 3.2% quarter-over-quarter to $463M.
Based on Bender Robert & Associates's 13F filing for Q3 2025, filed 22 Oct 2025.